Shala L. Thomas, Ph.D.
Affiliations: | 2009 | Biological and Biomedical Sciences | Emory University, Atlanta, GA |
Area:
Oncology, PharmacologyGoogle:
"Shala Thomas"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Thomas SL, Zhao J, Li Z, et al. (2010) Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy. Biochemical Pharmacology. 80: 1309-16 |
Thomas SL, Zhong D, Zhou W, et al. (2008) EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Cell Cycle (Georgetown, Tex.). 7: 2409-17 |
Kasinski AL, Du Y, Thomas SL, et al. (2008) Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Molecular Pharmacology. 74: 654-61 |
Marcus AI, O'Brate AM, Buey RM, et al. (2006) Farnesyltransferase inhibitors reverse taxane resistance. Cancer Research. 66: 8838-46 |
Marcus AI, Peters U, Thomas SL, et al. (2005) Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells. The Journal of Biological Chemistry. 280: 11569-77 |